1. Background

With the widespread adoption of Continuous Glucose Monitoring (CGM) systems in diabetes management, their technical limitations have become increasingly evident. A common artifact seen in clinical practice is compression-induced false hypoglycemia, commonly referred to as “compression low.” This typically occurs at night, presenting as low glucose alarms from CGM devices without symptoms or confirmation via capillary blood glucose testing.

This white paper aims to systematically analyze the mechanism, brand-specific differences, clinical identification, and management strategies of compression low based on published studies and manufacturer documentation, to help medical professionals enhance their ability to interpret CGM data anomalies.

2. Definition and Clinical Manifestations

Compression-induced false hypoglycemia refers to the inaccurate low glucose readings detected by CGM sensors under mechanical pressure (e.g., lying on the sensor during sleep), due to impaired interstitial fluid flow at the sensor site.

Common clinical signs include:

• Sudden drop and rapid recovery patterns on CGM curves during nighttime;
• Absence of typical hypoglycemia symptoms;
• Discrepancy between CGM readings and capillary blood glucose values;
• Sensor readings normalize after pressure is relieved.

3. Mechanisms

1. Restricted Interstitial Fluid Perfusion

CGM sensors measure glucose concentration in interstitial fluid, not directly in blood. External pressure reduces local capillary perfusion and slows interstitial fluid exchange, leading to artificially low readings.

2. Extended Lag Effect

After pressure is relieved, glucose recovery in the interstitial fluid takes time. This physiological lag causes continued falsely low readings even after the compression is gone.

3. Probe Displacement

Mechanical force may alter the insertion angle or depth of the sensor probe, shifting it to a low-perfusion or non-target area, thus compromising signal reliability.

4. Clinical Evidence and Frequency

Key Studies:

• Mensh BD, 2013, J Diabetes Sci Technol: Demonstrated significantly increased false low risk from sleeping on the sensor.
• Facchinetti A, 2016, Diabetes Technol Ther: Found that median compression low events lasted ~45 minutes (range 30–70 mins) in Dexcom G4 users, mostly occurring at night.
• Helton J, 2011: Modeled CGM errors based on interstitial fluid dynamics and first proposed compression-perfusion interplay as a mechanism.

Frequency Observations:

• Nighttime is a high-risk period, especially during prolonged sleep in one position;
• Sensors worn for longer durations, with poor fixation or improper adhesion, are more prone to this artifact;
• Most users may encounter 1–3 compression low events during a typical 7-day CGM cycle.

5. Brand-Specific Differences

Dexcom

• Official documentation explicitly acknowledges compression lows;
• Recommends sensor placement in low-pressure areas (e.g., lateral abdomen, back of the upper arm);
• G6/G7 systems offer faster recovery but cannot completely eliminate the issue.

Abbott FreeStyle Libre

• The user manual does not explicitly define compression low, but highlights that sensor dislodgement or poor adhesion can cause falsely low readings;
• Clinical reports indicate Libre 2/3 sensors are more susceptible, especially in lean individuals.

Medtronic Guardian Sensor

• Advises against sensor placement in areas prone to motion or compression;
• Compression-induced errors may falsely trigger SmartGuard automatic insulin suspension, affecting insulin delivery.

Senseonics Eversense (Implantable CGM)

• As a fully implantable sensor, Eversense is largely immune to external pressure effects;
• No reported cases of compression lows, making it unique among CGM systems.

BUZUD CGM

• BUZUD uses a subcutaneous sensor structure similar to traditional CGMs, supporting real-time glucose monitoring;
• Preliminary testing shows improved resistance to compression-related signal artifacts due to enhanced stability and adhesion;
• Compression lows may still occur; BUZUD advises avoiding sensor placement in areas likely to be compressed during sleep;
• If abnormal readings occur, users are encouraged to confirm via capillary blood glucose testing.

6. Clinical Management Recommendations

Identification Criteria:

• CGM curve shows sudden drop with rapid rebound, inconsistent with true hypoglycemia;
• No symptoms of hypoglycemia present;
• Strong correlation with sleep position or pressure on the sensor area.

Response Strategies:

1. Educate patients to choose sensor sites unlikely to be compressed while lying down;
2. Do not immediately treat CGM-reported lows with carbohydrates—verify with fingerstick first;
3. Label these events in medical records as “compression-induced artifacts” to avoid misdiagnosis or overtreatment;
4. If frequently recurring, reassess adhesion method and device stability, and contact manufacturer if needed;
5. Encourage CGM manufacturers to optimize algorithms that detect compression-related patterns to reduce false alarms.

7. Conclusion

Compression-induced false hypoglycemia is a CGM-specific artifact that poses challenges to accurate diabetes management. Its relatively frequent occurrence and potential clinical impact necessitate better understanding among healthcare providers.

By improving clinical recognition, educating users on proper placement and sleep behavior, and working with device manufacturers to enhance signal processing, the burden of this artifact on clinical decision-making can be significantly reduced.

It is recommended that all diabetes care teams include this topic in CGM interpretation training to strengthen understanding of device limitations and improve patient outcomes.